Heron Therapeutics, Inc. (HRTX)
Nasdaq: HRTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 1994
Filings
362 filings since 2017 beside 287 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026Due nextAccelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.
Filings a yearinsider forms included
6252706677548470
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jun 25, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Apr 6, 2026.SEC letters: 4 in the last 36 months, the newest Sep 12, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026
8-K items 1.01, 3.03, 7.01, 9.01
Major agreement signed; Change to shareholders' rights; Investor disclosure (Regulation FD) · Current report
Nov 8, 2026
Aug 14, 2026
8-K items 1.01, 3.03, 9.01
Major agreement signed; Change to shareholders' rights · Current report
Aug 13, 2026
Oct 29, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Oct 27, 2025
40 of 362 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.